Verified peer comparison
Cabot Corporation Common Stock vs Alnylam Pharmaceuticals, Inc. Financial Comparison
Cabot Corporation Common Stock versus Alnylam Pharmaceuticals, Inc. using 2025…
Direct answer
Cabot Corporation Common Stock and Alnylam Pharmaceuticals, Inc. are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Cabot Corporation Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Cabot Corporation Common Stock Revenue
- 3,713,000,000 USD
- Alnylam Pharmaceuticals, Inc. Revenue
- 3,713,937,000 USD
- Cabot Corporation Common Stock Operating income
- 621,000,000 USD
- Alnylam Pharmaceuticals, Inc. Operating income
- 501,578,000 USD